KWR

• GAAP net income was $26.8 million ($1.55 per diluted share) versus a net loss of $66.6 million ($3.78 loss per share) in Q2 2025.
• Non-GAAP net income was $37.9 million ($2.19 per diluted share), up 28% Y/Y; adjusted EBITDA was $85.2 million, up 13% Y/Y.
• The company increased its quarterly dividend by ~4.3% and repurchased $24.2 million of shares in Q2 2026; announced a new $250 million repurchase program.
• Management expects stable demand in Q3 2026 with flat to slightly positive end markets, and anticipates meaningful revenue and adjusted EBITDA growth for 2026.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• On June 30, 2026, Steven Dassing resigned as Vice President, Corporate Controller and Principal Accounting Officer, effective July 22, 2026.
• Upon Dassing's departure, CFO Mr. Coler (age 53) will also serve as Principal Accounting Officer.
• No new compensatory arrangements were made with Mr. Coler in connection with the additional role.
• Mr. Coler has no family relationships with directors/officers and no material interest in any required-disclosure transaction.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Mark A. Douglas, an independent director since 2013, was appointed Chairman effective May 13, 2026.
• The Board reduced its size from eleven to ten directors and eliminated the Lead Director role, effective May 13, 2026.
• Jeffry D. Frisby, former Lead Director, remains on the Board as Chair of the Sustainability Committee.
• Shareholders elected three directors and approved executive compensation and PwC as auditor at the 2026 Annual Meeting.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 5.07 Submission of Matters to a Vote of Security Holders · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• GAAP net income was $19.7 million, or $1.13 per diluted share, up from $12.9 million, or $0.73 per diluted share, in Q1 2025.
• Non-GAAP net income was $28.4 million, or $1.63 per diluted share, up 3% year-over-year; adjusted EBITDA was $72.5 million, up 5% from $69.0 million.
• The company amended its credit agreement, extending nearest-term debt maturity to 2031 and increasing available credit; net debt was approximately $705.3 million as of March 31, 2026.
• Management expects year-over-year revenue and adjusted EBITDA growth in 2026, with raw material inflation expected in Q2 and a new cost program targeting $20–30 million in annualized savings by 2028.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• The amendment establishes a $550 million U.S. dollar term loan, a €250 million equivalent euro term loan, and an $800 million revolving credit facility, all maturing April 10, 2031.
• Proceeds from the new term loans and revolving borrowings were used to repay all outstanding loans and terminate commitments under the existing credit agreement.
• The company may increase the facilities by up to $331 million plus other amounts, subject to conditions, and the credit agreement includes customary covenants and financial tests.
• CEO Joseph Berquist stated the amendment strengthens the balance sheet by extending maturities and enhancing liquidity to support strategic growth and M&A.

1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits

• Effective March 9, 2026, Jeffrey Fleck no longer serves as Senior Vice President, Chief Global Operations Officer of Quaker Chemical Corporation (Quaker Houghton).
• The separation is an involuntary termination without cause for purposes of all plan benefits and contractual entitlements, including his employment agreement dated January 23, 2023.
• Subject to executing a customary release of claims, Mr. Fleck will receive severance payments and benefits under the Fleck Employment Agreement and company plans as described in the Proxy Statement filed March 31, 2025.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Full-year 2025 net sales were $1.89 billion, with a net loss of $2.5 million and diluted loss per share of $0.14, including an $88.8 million impairment charge and $35.1 million in restructuring charges.
• Q4 2025 non-GAAP net income was $28.9 million and non-GAAP diluted EPS was $1.65, up 24% year-over-year; full-year non-GAAP net income was $123.2 million and non-GAAP diluted EPS was $7.02.
• Q4 2025 adjusted EBITDA was $71.9 million, up 11% year-over-year; full-year adjusted EBITDA was $299.2 million.
• The company generated $136.5 million in operating cash flow in 2025, completed three acquisitions, and returned $75.9 million to shareholders via dividends and buybacks.
• Management expects end markets to remain similar in the first half of 2026, with potential growth in the latter half, and anticipates revenue and adjusted EBITDA growth in 2026.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Q3 2025 net sales were $493.8 million, a 7% increase from $462.3 million in Q3 2024.
• Non-GAAP net income was $36.3 million, or $2.08 per diluted share, up 10% Y/Y from $34.0 million, or $1.89 per diluted share.
• Adjusted EBITDA was $82.9 million, up 5% Y/Y, with adjusted EBITDA margin of 16.8%.
• Company expects year-over-year revenue and earnings growth in Q4 2025, with soft end market conditions persisting through year end.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits